Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00158067 · ClinicalTrials.gov registry record · Phase 2
Study of an External Responsive Neurostimulator System on Epileptiform Activity
A Phase 2 study of Epilepsy, sponsored by NeuroPace.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
- 5
- Study locations
NCT00158067: Completed Phase 2 study of Epilepsy, sponsored by NeuroPace.
NCT00158067 is a Phase 2 study of Epilepsy that has completed, run by NeuroPace. The registered enrollment target is 150 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (84% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00158067, a Phase 2 study of Epilepsy, has completed, sponsored by NeuroPace.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
- 5
- Study locations
Study Summary
This feasibility clinical investigation is designed to demonstrate that the NeuroPace external Responsive Neurostimulator (model eRNS-300) can safely deliver responsive electrical stimulation automatically to affect epileptiform activity. The eRNS-300 is based on an implantable neurostimulator that has been adapted for acute, external use in a hospital setting.
Conditions Studied
Interventions
- DEVICE external Responsive Neurostimulator (eRNS) System
Study Locations (5)
Arizona
- Research Site - Scottsdale
Georgia
- Research Site - Augusta
Maryland
- Research Site - Baltimore
Minnesota
- Research Site - Rochester
New York
- Research Site - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2002-03 |
| Est. Completion | 2008-03 |
| Phase | Phase 2 |
What the finished NCT00158067 record still lists
NCT00158067 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which external Responsive Neurostimulator (eRNS) System is the first listed.
NCT00158067 lists 5 locations in 5 states (Arizona, Georgia, Maryland).
Frequently Asked Questions
What is clinical trial NCT00158067 about?
NCT00158067 is a clinical study titled "Study of an External Responsive Neurostimulator System on Epileptiform Activity". This feasibility clinical investigation is designed to demonstrate that the NeuroPace external Responsive Neurostimulator (model eRNS-300) can safely deliver responsive electrical stimulation automatically to affect epileptiform activity. The eRNS-300 is based on an implantable neurostimulator that ...
What is the current status of trial NCT00158067?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2002-03. Estimated completion is 2008-03.
What conditions does trial NCT00158067 study?
This clinical trial studies the following conditions: Epilepsy.
What interventions are being tested in trial NCT00158067?
The interventions under investigation include: external Responsive Neurostimulator (eRNS) System (DEVICE).
Who is sponsoring clinical trial NCT00158067?
This trial is sponsored by NeuroPace, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00158067 being conducted?
This trial has 5 study locations across Arizona, Georgia, Maryland, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00158067's enrollment target sits among peer trials
150 40th of 160 higher than 120 of 160 other Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
RECRUITING · Phase 2
-
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
RECRUITING · Phase 2
-
RNS System LGS Feasibility Study
ACTIVE NOT RECRUITING · Phase 2
-
Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI
COMPLETED · Phase 2
-
Hormone Replacement in Menopausal Women With Epilepsy
COMPLETED · Phase 2
-
Pediatric Epilepsy Study in Subjects 1-24 Months
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia